Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|July 24, 2008
Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival?Brian Badgwell, Janice N Cormier, Sunil Krishnan, et al.
The Kaohsiung Journal of Medical Sciences|May 4, 2013
Plasma B-type natriuretic peptide in predicting outcomes of elective coronary artery bypass surgeryThay-Hsiung Chen, Ching-Ling Lin, Joseph Jaey-Ming Shih, et al.
Cancer Research|June 3, 2005
Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasisDaoyan Wei, Weida Gong, Sang C Oh, et al.
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancerJaffer A Ajani, Josephine Faust, James Yao, et al.
Oncology Letters|April 5, 2019
The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatmentDinu Valentin Balanescu, Teodora Donisan, Juan Lopez-Mattei, et al.
The Oncologist|August 19, 2022
DLL3 as an Emerging Target for the Treatment of Neuroendocrine NeoplasmsJames Yao, Emily Bergsland, Rahul Aggarwal, et al.
Oncotarget|September 23, 2016
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinomaAhmed Omar Kaseb, Manal Hassan, Sahin Lacin, et al.
Digestive Diseases and Sciences|October 4, 2011
EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experienceMuslim Atiq, Manoop S Bhutani, Mehmet Bektas, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 17, 2016
Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine TumorsLaura Prakash, Priya Bhosale, Jordan Cloyd, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2005
Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapyZhen Zhang, Zhongxing Liao, Jing Jin, et al.
Pageof 7